Cengild Medical Berhad (KLSE:CENGILD)
Malaysia · Delayed Price · Currency is MYR 0.2200
+0.0100 (4.76%)
At close: May 15, 2026
Cengild Medical Berhad Cash Flow Statement
Financials in millions MYR. Fiscal year is July - June.
Millions MYR. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Net Income | 9.69 | 11.06 | 11.08 | 13.29 | 9.39 | 10 |
Depreciation & Amortization | 6.18 | 6.5 | 4.01 | 3.17 | 4.41 | 4.86 |
Other Amortization | - | - | - | 0.15 | 1.27 | - |
Loss (Gain) From Sale of Assets | 0.6 | 0.6 | - | - | - | - |
Asset Writedown & Restructuring Costs | 0.02 | 0.01 | 0 | 0.01 | 0 | - |
Loss (Gain) on Equity Investments | -0.87 | -0.47 | 0.35 | - | - | 0 |
Stock-Based Compensation | 0.12 | 0.18 | 0.26 | 0.39 | 0.09 | - |
Provision & Write-off of Bad Debts | 0.49 | 0.49 | 0 | 0.03 | 0 | - |
Other Operating Activities | -1.65 | -0.03 | -1.42 | -2.31 | -1.25 | 1.05 |
Change in Accounts Receivable | 0.35 | -5.17 | -1.66 | -0.3 | -0.89 | -1.19 |
Change in Inventory | -0.03 | -0.48 | -0.34 | -0.23 | -0.21 | -0.17 |
Change in Accounts Payable | -6.7 | 5.67 | 1.53 | -0.28 | 2.38 | 0.82 |
Change in Other Net Operating Assets | -0.03 | 0.03 | 0 | -0.01 | 0.13 | -1.07 |
Operating Cash Flow | 6.93 | 16.08 | 12.94 | 13.91 | 15.33 | 14.3 |
Operating Cash Flow Growth | -69.14% | 24.30% | -7.02% | -9.24% | 7.21% | 27.22% |
Capital Expenditures | -64.19 | -37.26 | -15.73 | -2.13 | -0.43 | -1.7 |
Sale of Property, Plant & Equipment | 0.06 | 0.13 | 0.39 | - | - | - |
Cash Acquisitions | - | - | - | - | 0 | - |
Divestitures | -0.05 | -0.05 | - | - | - | - |
Investment in Securities | 14.97 | 13.41 | -67.45 | 50 | -48 | -2 |
Other Investing Activities | 25.81 | 3.14 | 3.36 | 2.78 | 0.5 | 0.06 |
Investing Cash Flow | -23.4 | -20.63 | -79.43 | 50.65 | -47.93 | -3.64 |
Long-Term Debt Issued | - | 25.69 | - | - | - | - |
Short-Term Debt Repaid | - | - | - | - | -2.02 | -4 |
Long-Term Debt Repaid | - | -2.45 | -1.7 | -1.27 | -0.96 | -0.74 |
Total Debt Repaid | -2.43 | -2.45 | -1.7 | -1.27 | -2.98 | -4.74 |
Net Debt Issued (Repaid) | 33.97 | 23.24 | -1.7 | -1.27 | -2.98 | -4.74 |
Issuance of Common Stock | - | - | 0.01 | 5.63 | 72.2 | - |
Common Dividends Paid | -8.08 | -8.08 | -6.16 | -6.06 | - | -7.28 |
Other Financing Activities | -0.22 | -0.29 | -0.6 | -0.94 | -4.47 | 0.05 |
Financing Cash Flow | 25.67 | 14.87 | -8.45 | -2.65 | 64.76 | -11.98 |
Net Cash Flow | 9.2 | 10.32 | -74.94 | 61.92 | 32.16 | -1.32 |
Free Cash Flow | -57.26 | -21.18 | -2.8 | 11.78 | 14.9 | 12.6 |
Free Cash Flow Growth | - | - | - | -20.92% | 18.27% | 18.55% |
Free Cash Flow Margin | -76.41% | -26.48% | -4.19% | 16.77% | 23.12% | 19.85% |
Free Cash Flow Per Share | -0.07 | -0.03 | -0.00 | 0.01 | 0.02 | 0.02 |
Cash Interest Paid | 0.22 | 0.29 | 0.6 | 0.7 | 0.85 | 1.22 |
Cash Income Tax Paid | 4.14 | 4.26 | 4.33 | 4.34 | 4.32 | 3.57 |
Levered Free Cash Flow | -58.04 | -20.63 | -3.2 | 9.38 | 13.4 | 9.72 |
Unlevered Free Cash Flow | -57.83 | -20.39 | -2.82 | 9.84 | 13.93 | 10.48 |
Change in Working Capital | -6.42 | 0.05 | -0.46 | -0.82 | 1.41 | -1.62 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.